Plasma Metabolite Biomarkers Related to Secondary Hyperparathyroidism and Parathyroid Hormone.
Qixia Shen,Wenyu Xiang,Sen Ye,Xin Lei,Lefeng Wang,Sha Jia,Xue Shao,Chunhua Weng,Xiujin Shen,Yucheng Wang,Shi Feng,Lihui Qu,Cuili Wang,Jianghua Chen,Ping Zhang,Hong Jiang
DOI: https://doi.org/10.1002/jcb.28846
2019-01-01
Journal of Cellular Biochemistry
Abstract:Background Hyperphosphatemia, hypocalcemia, and elevation of parathyroid hormone (PTH) are typical abnormalities of uremic patients with Secondary hyperparathyroidism (SHPT). However, metabolic imbalance associated with SHPT is not well understood. Methods A total of 15 SHPT patients with an intact parathyroid hormone (iPTH) level > 600 pg/mL were set as preoperative (PR) group, 15 age- and gender-matched controls who had undergone parathyroidectomy plus forearm transplantation because of hyperparathyroidism and achieved an iPTH level <150 pg/mL were set as postoperative (PO) group. Metabolite profiling of these 30 uremic patients and five healthy controls (HC) was performed using ultra performance liquid chromatography-mass spectrometry. Results Five differential metabolites, including allyl isothiocyanate, L-phenylalanine, D-Aspartic acid, indoleacetaldehyde, and D-galactose correlated with PTH were identified in this study. Taking them as a biomarker signature, PR group can be distinguished from HC group with an area under the curve (AUC) of 0.947 (95% CI, 0.76-1) and PO group with an AUC of 0.6 (95% CI, 0.38-0.807). Conclusions The serum metabolome correlated with PTH is successfully demonstrated for a better understanding of the pathogenesis of SHPT.